StockWatch: Verve Investors Accentuate the Negative as Shares Tumble, Then Recover genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
SciSparc (SPRC) unveiles positive topline results from investigator-initiated Phase IIa trial at the Sophie & Abraham Stuchynski Israeli Alzheimer s Medical Center streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of SciSparc Ltd. (SPRC) are up 48% on Wednesday after the company shared the topline results of its Phase IIa clinical trial, which indicated that SCI-110 is a safe and effective treatment option for this debilitating symptom of Alzheimer's Disease (AD).
SciSparc Ltd (NASDAQ: SPRC) shares are trading higher Wednesday after the company announced positive results from the Phase IIa clinical trial of its investigational compound for the
SciSparc (SPRC) Announces Successful Final Phase IIa Results, Meeting End Points of its Phase IIa Alzheimer Disease Patients with Agitation Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.